Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_47544 | 42 | 0.88 | Mlig455_055595, Mlig455_055624 | Neo: - Age: - |
RASL10B | Mlig455_055595 {REF} {Length: 1887} {Pfam: Ras family [PF00071.24, score=75.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=34.0]; AAA ATPase domain [PF13191.8, score=20.2]} {Human: ENSG00000270885, RASL10B, RAS like family 10 member B, [Score=151, Expect=2e-44]} {Mouse: ENSMUSG00000020684, Rasl10b, RAS-like, family 10, member B, [Score=151, Expect=2e-44]} {Dmel: FBgn0037326, CG14669, [Score=112, Expect=1e-28]} {Celegans: WBGene00004307, rap-1, Ras-related protein Rap-1, [Score=54.7, Expect=7e-09]} {Smed: dd_Smed_v6_13540_0_1, dd_Smed_v6_13540_0_1, [Score=186, Expect=3e-57]} {RNA1310_59421} {RNA815_58204} Mlig455_055624 {REF} {Length: 1840} {Pfam: Ras family [PF00071.24, score=74.4]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=33.3]; AAA ATPase domain [PF13191.8, score=19.8]} {Human: ENSG00000270885, RASL10B, RAS like family 10 member B, [Score=150, Expect=4e-44]} {Mouse: ENSMUSG00000020684, Rasl10b, RAS-like, family 10, member B, [Score=152, Expect=6e-45]} {Dmel: FBgn0037326, CG14669, [Score=111, Expect=2e-28]} {Celegans: WBGene00004307, rap-1, Ras-related protein Rap-1, [Score=56.2, Expect=2e-09]} {Smed: dd_Smed_v6_13540_0_1, dd_Smed_v6_13540_0_1, [Score=186, Expect=3e-57]} {RNA1310_59421} {RNA815_58204} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 2.127 | 1.299 | 1.00000 | 1.00000 | |
RegionR2 | 2.463 | 1.299 | 0.25890 | 0.63977 | |
RegionR3 | 0.432 | 1.299 | 0.58559 | 1.00000 | |
RegionR4 | 1.469 | 1.299 | 0.28860 | 0.59880 | |
RegionR5 | -2.029 | 1.299 | 0.94564 | 1.00000 | |
RegionR6 | -4.708 | 1.299 | 1.00000 | 1.00000 | |
RegionR7 | 2.69 | 1.299 | 0.15796 | 0.73412 | |
RegionR8 | -2.444 | 1.299 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -5.166 | 1.299 | 0.99985 | 1.00000 | |
RegenerationR2 | -3.339 | 1.299 | 0.00202 | 0.06863 | |
RegenerationR3 | -2.307 | 1.299 | 0.09095 | 0.48697 | |
RegenerationR4 | -2.275 | 1.299 | 0.10914 | 0.50799 | |
RegenerationR5 | -0.097 | 1.299 | 0.78467 | 0.98313 | |
RegenerationR6 | 0.765 | 1.299 | 0.54129 | 0.83345 | |
RegenerationBL | -4.245 | 1.299 | 1.00000 | 1.00000 | |
RegenerationTP | -0.333 | 1.299 | 0.88142 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_47544 | 42 | 0.88 | Mlig455_055595, Mlig455_055624 | Neo: - Age: - |
RASL10B | 5 | 1.000 | 1.000 | 1.000 | - | 1.000 | 1.000 | Mlig455_055595 {REF} {Length: 1887} {Pfam: Ras family [PF00071.24, score=75.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=34.0]; AAA ATPase domain [PF13191.8, score=20.2]} {Human: ENSG00000270885, RASL10B, RAS like family 10 member B, [Score=151, Expect=2e-44]} {Mouse: ENSMUSG00000020684, Rasl10b, RAS-like, family 10, member B, [Score=151, Expect=2e-44]} {Dmel: FBgn0037326, CG14669, [Score=112, Expect=1e-28]} {Celegans: WBGene00004307, rap-1, Ras-related protein Rap-1, [Score=54.7, Expect=7e-09]} {Smed: dd_Smed_v6_13540_0_1, dd_Smed_v6_13540_0_1, [Score=186, Expect=3e-57]} {RNA1310_59421} {RNA815_58204} Mlig455_055624 {REF} {Length: 1840} {Pfam: Ras family [PF00071.24, score=74.4]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=33.3]; AAA ATPase domain [PF13191.8, score=19.8]} {Human: ENSG00000270885, RASL10B, RAS like family 10 member B, [Score=150, Expect=4e-44]} {Mouse: ENSMUSG00000020684, Rasl10b, RAS-like, family 10, member B, [Score=152, Expect=6e-45]} {Dmel: FBgn0037326, CG14669, [Score=111, Expect=2e-28]} {Celegans: WBGene00004307, rap-1, Ras-related protein Rap-1, [Score=56.2, Expect=2e-09]} {Smed: dd_Smed_v6_13540_0_1, dd_Smed_v6_13540_0_1, [Score=186, Expect=3e-57]} {RNA1310_59421} {RNA815_58204} |
2. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
3.491 | 0.893 | 0.951 | 0.770 | - | 0.877 | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
3. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 3.47 | 0.869 | 0.965 | 0.782 | - | 0.854 | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
4. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
3.461 | 0.874 | 0.954 | 0.790 | - | 0.843 | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
5. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 3.389 | 0.836 | 0.954 | 0.822 | - | 0.777 | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
6. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
3.294 | 0.783 | 0.950 | 0.747 | - | 0.814 | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
7. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 3.291 | - | 0.960 | 0.745 | - | 0.870 | 0.716 | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
8. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
2.714 | 0.886 | 0.951 | - | - | 0.877 | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
9. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
2.702 | - | 0.951 | 0.856 | - | 0.895 | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
10. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 2.697 | - | 0.995 | 0.799 | - | 0.903 | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
11. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 2.688 | 0.831 | 0.954 | - | - | 0.903 | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
12. | MligTC455_43382 | 30 | 0.63 | Mlig455_035066 | Neo: - Age: Up-Up-Down |
KIAA0513 | 2.682 | 0.926 | - | - | - | 0.956 | 0.800 | Mlig455_035066 {REF} {Length: 5084} {Pfam: Myotubularin protein [PF12335.10, score=30.0]} {Human: ENSG00000135709, KIAA0513, KIAA0513, [RH, Score=107, Expect=7e-25]} {Mouse: ENSMUSG00000031824, 6430548M08Rik, RIKEN cDNA 6430548M08 gene, [RH, Score=107, Expect=5e-25]} {Dmel: FBgn0031858, CG17378, [RH, Score=108, Expect=8e-24]} {Smed: dd_Smed_v6_3628_0_1, dd_Smed_v6_3628_0_1, [RH, Score=123, Expect=2e-30]} {RNA1509_34970} {RNA1310_2885} {RNA815_12050} |
13. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 2.681 | 0.905 | 0.954 | - | - | 0.822 | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
14. | MligTC455_05494 | 51 | 1.06 | Mlig455_004276, Mlig455_004287, Mlig455_004362 | Neo: - Age: - |
2.673 | 0.964 | 0.885 | 0.824 | - | - | - | Mlig455_004276 {REF} {Length: 1694} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=48.1]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.2]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [RH, Score=151, Expect=1e-41]} {RNA1310_39315} {RNA815_27280} Mlig455_004287 {REF} {Length: 4218} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=48.1]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.2]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [RH, Score=151, Expect=1e-41]} {RNA1509_28642} {RNA1310_39315} {RNA815_27280} Mlig455_004362 {REF} {Length: 400} {NoTransDecoderORF} {RNA1310_149581} |
|
15. | MligTC455_37701 | 47 | 0.98 | Mlig455_029831 | Neo: - Age: - Region-enriched R2: 8.298/0.02665 |
2.664 | - | 0.922 | 0.789 | - | 0.953 | - | Mlig455_029831 {REF} {Length: 724} {RNA1310_73844} | |
16. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
2.632 | - | 0.954 | 0.778 | - | 0.900 | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
17. | MligTC455_10227 | 76 | 1.59 | Mlig455_023507, Mlig455_023516, Mlig455_023551 | Neo: - Age: - |
2.628 | - | 0.953 | 0.777 | - | 0.898 | - | Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050} Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050} Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1} |
|
18. | MligTC455_43261 | 41 | 0.86 | Mlig455_065982 | Neo: - Age: - |
2.628 | - | 0.867 | 0.805 | - | 0.956 | - | Mlig455_065982 {REF} {Length: 581} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
19. | MligTC455_41723 | 46 | 0.97 | Mlig455_001714 | Neo: - Age: - |
2.615 | 0.851 | - | 0.979 | - | 0.785 | - | Mlig455_001714 {REF} {Length: 1881} {RNA1310_22665} {RNA815_13308} | |
20. | MligTC455_13049 | 53 | 1.11 | Mlig455_029230, Mlig455_029252, Mlig455_035639, Mlig455_035735 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.077/0.00215 |
HTR2A | 2.599 | 0.846 | 0.954 | 0.799 | - | - | - | Mlig455_029230 {REF} {Length: 2756} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=149.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.6]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=24.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.2]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=142, Expect=3e-37]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=141, Expect=5e-37]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=138, Expect=8e-36]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=131, Expect=1e-32]} {Celegans: WBGene00004776, ser-1, SERotonin/octopamine receptor family; Serotonin receptor, [Score=120, Expect=2e-29]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=281, Expect=8e-90]} {RNA1310_91864} Mlig455_029252 {REF} {Length: 2844} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=188.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.8]; Spt20 family [PF12090.10, score=21.4]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=142, Expect=4e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=140, Expect=1e-35]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=136, Expect=2e-33]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=157, Expect=2e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=336, Expect=4e-108]} {RNA1310_91864} Mlig455_035639 {REF} {Length: 2811} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=182.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.7]; Spt20 family [PF12090.10, score=24.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=143, Expect=3e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=141, Expect=1e-35]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=133, Expect=6e-32]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=156, Expect=5e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=284, Expect=3e-88]} {RNA1310_91864} Mlig455_035735 {REF} {Length: 1469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=140.9]; Spt20 family [PF12090.10, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=97.1, Expect=3e-21]; ENSG00000147246, HTR2C, 5-hydroxytryptamine receptor 2C, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=95.5, Expect=1e-20]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=93.2, Expect=6e-20]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=89.0, Expect=2e-18]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=115, Expect=1e-27]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=249, Expect=4e-77]} {RNA1310_91864} |
21. | MligTC455_08098 | 15 | 0.31 | Mlig455_029099 | Neo: - Age: - Region-enriched R2: 8.013/0.00338 |
2.435 | - | 0.954 | 0.728 | - | 0.753 | - | Mlig455_029099 {REF} {Length: 1334} {RNA1310_58776} {RNA815_46110} | |
22. | MligTC455_32391 | 75 | 1.56 | Mlig455_017179, Mlig455_048147 | Neo: - Age: - |
SDCBP2 | 2.419 | 0.702 | 0.763 | - | - | 0.954 | - | Mlig455_017179 {REF} {Length: 3606} {Pfam: PDZ domain [PF00595.26, score=88.1]; PDZ domain [PF17820.3, score=72.4]; PDZ domain [PF13180.8, score=47.6]; Immunoglobulin domain [PF13927.8, score=44.1]; Immunoglobulin domain [PF00047.27, score=37.4]; Immunoglobulin V-set domain [PF07686.19, score=35.7]; Immunoglobulin I-set domain [PF07679.18, score=25.6]} {Human: ENSG00000125775, SDCBP2, syndecan binding protein 2, [Score=59.3, Expect=2e-09]; ENSG00000006611, USH1C, USH1 protein network component harmonin, [Score=56.6, Expect=2e-07]} {Mouse: ENSMUSG00000038298, Pdzk1, PDZ domain containing 1, [Score=60.1, Expect=8e-09]; ENSMUSG00000030838, Ush1c, USH1 protein network component harmonin, [Score=60.1, Expect=1e-08]; ENSMUSG00000027456, Sdcbp2, syndecan binding protein (syntenin) 2, [Score=59.3, Expect=5e-09]} {Dmel: FBgn0029835, CG5921, [Score=55.1, Expect=2e-07]} {Celegans: WBGene00003404, mpz-1, Multiple PDZ domain protein, [Score=63.2, Expect=7e-10]} {Smed: dd_Smed_v6_21860_0_1, dd_Smed_v6_21860_0_1, [RH, Score=146, Expect=2e-38]} {RNA1509_22767} {RNA1310_28491} {RNA815_60114} Mlig455_048147 {REF} {Length: 2119} {Pfam: Immunoglobulin domain [PF13927.8, score=47.4]; Immunoglobulin domain [PF00047.27, score=41.5]; Immunoglobulin V-set domain [PF07686.19, score=40.0]; Immunoglobulin I-set domain [PF07679.18, score=29.2]; Immunoglobulin domain [PF13895.8, score=25.4]} {RNA1509_22767} {RNA1310_34847} |
23. | MligTC455_39078 | 130 | 2.7 | Mlig455_060090 | Neo: - Age: - |
1.877 | 0.924 | - | - | - | 0.953 | - | Mlig455_060090 {REF} {Length: 493} {NoTransDecoderORF} {RNA1509_45542} {RNA1310_46086} {RNA815_33321.1} | |
24. | MligTC455_17394 | 41 | 0.85 | Mlig455_013077 | Neo: - Age: - |
1.836 | - | 0.950 | - | - | 0.886 | - | Mlig455_013077 {REF} {Length: 1066} {RNA1310_66954} {RNA815_27868} | |
25. | MligTC455_53826 | 179 | 3.73 | Mlig455_013881 | Neo: - Age: - |
1.833 | - | - | 0.950 | - | 0.883 | - | Mlig455_013881 {REF} {Length: 694} {RNA1310_41119} {RNA815_15825} | |
26. | MligTC455_12914 | 32 | 0.66 | Mlig455_026496 | Neo: - Age: - |
ZNF521 | 1.821 | - | - | 0.856 | - | 0.965 | - | Mlig455_026496 {REF} {Length: 3383} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=54.4]; C2H2-type zinc finger [PF13894.8, score=52.8]; Zinc-finger of C2H2 type [PF12874.9, score=31.6]; Zinc-finger double domain [PF13465.8, score=19.7]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=19.2]; C2H2-type zinc finger [PF13912.8, score=18.7]} {Human: ENSG00000198795, ZNF521, zinc finger protein 521, [Score=77.0, Expect=1e-13]} {Mouse: ENSMUSG00000024420, Zfp521, zinc finger protein 521, [Score=75.5, Expect=3e-13]} {Dmel: FBgn0036179, CG7368, [Score=72.4, Expect=1e-12]} {Celegans: WBGene00018567, F47E1.3, [Score=61.6, Expect=2e-09]} {Smed: dd_Smed_v6_7731_0_1, dd_Smed_v6_7731_0_1, [Score=58.5, Expect=1e-09]} {RNA1310_43017} {RNA815_23872} |
27. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 1.812 | 0.968 | - | - | - | 0.844 | - | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
28. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 1.787 | 0.812 | 0.975 | - | - | - | - | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
29. | MligTC455_50844 | 224 | 4.67 | Mlig455_018511 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.591/0.00005 |
SSUH2 | 1.774 | 0.957 | - | - | - | 0.817 | - | Mlig455_018511 {REF} {Length: 1843} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=120, Expect=2e-29]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=95.5, Expect=3e-21]} {RNA1509_39980} {RNA1310_60742, RNA1509_39980} {RNA1509_39980, RNA815_28938} |
30. | MligTC455_47997 | 36 | 0.75 | Mlig455_053262, Mlig455_065031 | Neo: - Age: - |
1.764 | - | 0.954 | 0.810 | - | - | - | Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2} Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2} |
|
31. | MligTC455_48523 | 615 | 12.81 | Mlig455_027573 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.661 Region-enriched R2: 5.785/0.00008 |
1.762 | - | 0.952 | - | - | 0.810 | - | Mlig455_027573 {REF} {Length: 1106} {TRANSSPLICED} {Pfam: N-formylglutamate amidohydrolase [PF05013.14, score=30.2]} {RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1310_12591, RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1509_25119, RNA1509_35691, RNA1509_59740, RNA815_14574} | |
32. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
1.758 | - | 0.965 | 0.793 | - | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
33. | MligTC455_24568 | 25 | 0.51 | Mlig455_038127 | Neo: - Age: Down-Up-Down |
CACNA2D2 | 1.749 | 0.950 | - | 0.799 | - | - | - | Mlig455_038127 {REF} {Length: 4202} {Pfam: von Willebrand factor type A domain [PF13519.8, score=41.5]; von Willebrand factor type A domain [PF00092.30, score=36.2]; von Willebrand factor type A domain [PF13768.8, score=30.8]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=82.8, Expect=2e-16]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=79.3, Expect=3e-15]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=79.0, Expect=4e-15]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=82.4, Expect=2e-16]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=79.3, Expect=3e-15]} {Celegans: WBGene00007041, tag-180, [Score=62.0, Expect=4e-10]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=430, Expect=2e-140]} {RNA1509_28096} {RNA1310_2030} {RNA815_1872} |
34. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 1.734 | - | 0.976 | 0.758 | - | - | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
35. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
1.719 | - | 0.960 | 0.759 | - | - | - | Mlig455_065030 {REF} {Length: 672} | |
36. | MligTC455_48192 | 17 | 0.36 | Mlig455_020984 | Neo: - Age: Down-Down-Up |
DLG1 | 1.701 | - | - | 0.730 | - | 0.971 | - | Mlig455_020984 {REF} {Length: 2812} {Pfam: Guanylate kinase [PF00625.23, score=174.6]; PDZ domain [PF00595.26, score=49.2]; Variant SH3 domain [PF07653.19, score=34.8]; SH3 domain [PF00018.30, score=30.1]; PDZ domain [PF17820.3, score=19.7]} {Human: ENSG00000075711, DLG1, discs large MAGUK scaffold protein 1, [Score=430, Expect=1e-137]; ENSG00000150672, DLG2, discs large MAGUK scaffold protein 2, [Score=426, Expect=4e-135]} {Mouse: ENSMUSG00000052572, Dlg2, discs large MAGUK scaffold protein 2, [RH, Score=426, Expect=1e-141]} {Dmel: FBgn0001624, dlg1, discs large 1, [RH, Score=437, Expect=4e-140]} {Celegans: WBGene00001006, dlg-1, Drosophila Discs LarGe homolog; MAGUK protein DLG-1; SAP97-like protein DLG-1, [Score=345, Expect=2e-105]} {Smed: dd_Smed_v6_8511_0_1, dd_Smed_v6_8511_0_1, [Score=298, Expect=6e-92]} {RNA1509_59616} {RNA1310_7336} {RNA815_36982} |
37. | MligTC455_47927 | 43 | 0.9 | Mlig455_029720 | Neo: - Age: - |
1.693 | 0.739 | 0.954 | - | - | - | - | Mlig455_029720 {REF} {Length: 2459} {RNA1509_35671} {RNA1310_75812} {RNA815_33002} | |
38. | MligTC455_23833 | 17 | 0.36 | Mlig455_016419 | Neo: - Age: - |
MYT1 | 1.68 | - | 0.976 | - | - | 0.704 | - | Mlig455_016419 {REF} {Length: 2682} {Pfam: Zinc finger, C2HC type [PF01530.20, score=79.8]} {Human: ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=130, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=125, Expect=3e-30]} {Mouse: ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=132, Expect=6e-33]; ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=1e-31]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=126, Expect=2e-30]} {Dmel: FBgn0263772, CG43689, [RH, Score=99.0, Expect=1e-21]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=121, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_2, dd_Smed_v6_80183_0_2, [Score=127, Expect=4e-34]} {RNA1310_143021} |
39. | MligTC455_56114 | 10 | 0.2 | Mlig455_062554 | Neo: - Age: - |
0.994 | - | - | - | - | - | 0.994 | Mlig455_062554 {REF} {Length: 435} {NoTransDecoderORF} {RNA1509_2762} {RNA1310_23298} {RNA815_59053.1} | |
40. | MligTC455_11717 | 89 | 1.85 | Mlig455_061662, Mlig455_061663 | Neo: - Age: - |
0.993 | - | - | 0.993 | - | - | - | Mlig455_061662 {REF} {Length: 1100} {RNA1509_13494} {RNA1310_72946} {RNA815_44318} Mlig455_061663 {REF} {Length: 1440} {RNA1310_86013} {RNA815_53527} |
|
41. | MligTC455_23950 | 72 | 1.51 | Mlig455_015170, Mlig455_015294 | Neo: - Age: - |
0.99 | - | 0.990 | - | - | - | - | Mlig455_015170 {REF} {Length: 1690} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=49.7]} {RNA1310_34740} {RNA815_15663} Mlig455_015294 {REF} {Length: 1451} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=56.9]} {RNA1310_34740} {RNA815_15663} |
|
42. | MligTC455_50029 | 35 | 0.74 | Mlig455_010619, Mlig455_010708 | Neo: - Age: - |
FOXA1 | 0.98 | - | - | 0.980 | - | - | - | Mlig455_010619 {REF} {Length: 1170} {Pfam: Forkhead domain [PF00250.20, score=110.8]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000170608, FOXA3, forkhead box A3, [Score=164, Expect=1e-47]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=3e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=164, Expect=7e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=7e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=169, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=150, Expect=3e-42]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=175, Expect=2e-51]} Mlig455_010708 {REF} {Length: 1194} {Pfam: Forkhead domain [PF00250.20, score=110.9]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]; ENSG00000170608, FOXA3, forkhead box A3, [Score=163, Expect=1e-47]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=4e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=165, Expect=2e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=9e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=168, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=151, Expect=2e-42]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=175, Expect=2e-51]} |
43. | MligTC455_02646 | 161 | 3.36 | Mlig455_046275 | Neo: - Age: - |
0.978 | - | - | 0.978 | - | - | - | Mlig455_046275 {REF} {Length: 460} {Celegans: WBGene00022511, ZC53.4, [Score=95.9, Expect=6e-24]} {Smed: dd_Smed_v6_15026_0_1, dd_Smed_v6_15026_0_1, [Score=65.5, Expect=8e-15]} {RNA1509_28643} {RNA1310_576.1} {RNA815_1671.1} | |
44. | MligTC455_12978 | 63 | 1.31 | Mlig455_023948 | Neo: - Age: - |
0.976 | - | 0.976 | - | - | - | - | Mlig455_023948 {REF} {Length: 2929} {RNA1310_80095.1} | |
45. | MligTC455_33853 | 7 | 0.14 | Mlig455_029940 | Neo: - Age: - |
MGAT1 | 0.976 | - | 0.976 | - | - | - | - | Mlig455_029940 {REF} {Length: 2088} {Pfam: GNT-I family [PF03071.17, score=204.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=153, Expect=4e-41]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=166, Expect=4e-46]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=172, Expect=3e-48]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=144, Expect=2e-38]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=158, Expect=1e-43]} {RNA1310_114996} |
46. | MligTC455_01861 | 30 | 0.63 | Mlig455_046027 | Neo: - Age: - |
0.975 | - | 0.975 | - | - | - | - | Mlig455_046027 {REF} {Length: 736} {RNA1310_50531} {RNA815_29422} | |
47. | MligTC455_11495 | 71 | 1.49 | Mlig455_038430 | Neo: - Age: - |
0.975 | - | - | 0.975 | - | - | - | Mlig455_038430 {REF} {Length: 443} {NoTransDecoderORF} {RNA1509_51837} {RNA1310_23145} {RNA815_41033.2} | |
48. | MligTC455_30711 | 92 | 1.93 | Mlig455_054511 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_054511 {REF} {Length: 3241} {RNA1509_31175} {RNA1310_13662} {RNA815_18675} | |
49. | MligTC455_37637 | 94 | 1.96 | Mlig455_008311 | Neo: - Age: - |
0.974 | - | - | 0.974 | - | - | - | Mlig455_008311 {REF} {Length: 2111} {Pfam: Adenovirus late L2 mu core protein (Protein X) [PF05829.14, score=31.4]} {RNA1509_21400} {RNA1310_6101.1} {RNA815_2733.1} | |
50. | MligTC455_52926 | 9 | 0.18 | Mlig455_024897 | Neo: - Age: - |
0.973 | - | 0.973 | - | - | - | - | Mlig455_024897 {REF} {Length: 428} {NoTransDecoderORF} {RNA1310_119495} | |
51. | MligTC455_08724 | 7 | 0.14 | Mlig455_008878 | Neo: - Age: - |
TENT5D | 0.972 | - | 0.972 | - | - | - | - | Mlig455_008878 {REF} {Length: 2482} {Pfam: Nucleotidyltransferase [PF07984.14, score=304.0]} {Human: ENSG00000174016, TENT5D, terminal nucleotidyltransferase 5D, [Score=248, Expect=8e-77]; ENSG00000183508, TENT5C, terminal nucleotidyltransferase 5C, [Score=246, Expect=4e-76]; ENSG00000112773, TENT5A, terminal nucleotidyltransferase 5A, [Score=239, Expect=1e-72]} {Mouse: ENSMUSG00000073007, Tent5d, terminal nucleotidyltransferase 5D, [Score=244, Expect=8e-76]; ENSMUSG00000044468, Tent5c, terminal nucleotidyltransferase 5C, [Score=243, Expect=3e-75]; ENSMUSG00000032265, Tent5a, terminal nucleotidyltransferase 5A, [Score=242, Expect=2e-74]} {Dmel: FBgn0050497, CG30497, [Score=244, Expect=2e-74]} {Celegans: WBGene00004131, pqn-44, Prion-like-(Q/N-rich)-domain-bearing protein, [RH, Score=209, Expect=2e-61]} {Smed: dd_Smed_v6_11571_0_1, dd_Smed_v6_11571_0_1, [Score=254, Expect=8e-80]} {RNA1310_116080} |
52. | MligTC455_11496 | 45 | 0.94 | Mlig455_038429 | Neo: - Age: - |
0.971 | - | - | 0.971 | - | - | - | Mlig455_038429 {REF} {Length: 603} {NoTransDecoderORF} {RNA1509_51837} {RNA1310_8956.1} {RNA815_41033.2} | |
53. | MligTC455_35783 | 47 | 0.99 | Mlig455_020624 | Neo: - Age: - |
0.97 | 0.970 | - | - | - | - | - | Mlig455_020624 {REF} {Length: 2007} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=58.9]} {Smed: dd_Smed_v6_14040_0_1, dd_Smed_v6_14040_0_1, [Score=64.3, Expect=2e-11]} {RNA1310_46235} {RNA815_34663} | |
54. | MligTC455_35894 | 23 | 0.48 | Mlig455_029906 | Neo: - Age: - |
RYK | 0.969 | 0.969 | - | - | - | - | - | Mlig455_029906 {REF} {Length: 3571} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=210.1]; WIF domain [PF02019.20, score=110.2]; Protein kinase domain [PF00069.27, score=79.8]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=7e-57]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [Score=202, Expect=9e-57]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=241, Expect=7e-71]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [RH, Score=179, Expect=9e-49]} {Smed: dd_Smed_v6_12594_0_3, dd_Smed_v6_12594_0_3, [Score=201, Expect=2e-56]} {RNA1509_58811} {RNA1310_6671.2, RNA1509_58811} {RNA1509_58811, RNA815_41921} |
55. | MligTC455_46281 | 22 | 0.45 | Mlig455_016138 | Neo: Irradiation Age: - |
KDELR2 | 0.969 | - | 0.969 | - | - | - | - | Mlig455_016138 {REF} {Length: 2664} {TRANSSPLICED} {Pfam: ER lumen protein retaining receptor [PF00810.20, score=173.9]; Intermediate filament protein [PF00038.23, score=132.5]; Lamin Tail Domain [PF00932.21, score=37.2]} {Human: ENSG00000136240, KDELR2, KDEL endoplasmic reticulum protein retention receptor 2, [Score=293, Expect=2e-93]} {Mouse: ENSMUSG00000079111, Kdelr2, KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2, [Score=296, Expect=1e-94]} {Dmel: FBgn0267330, KdelR, KDEL receptor, [Score=291, Expect=4e-93]} {Celegans: WBGene00001331, erd-2, ER lumen protein-retaining receptor, [Score=266, Expect=2e-83]} {Smed: dd_Smed_v6_1592_0_1, dd_Smed_v6_1592_0_1, [Score=283, Expect=8e-90]} {RNA1509_3479} {RNA1310_8292} {RNA815_3092.1} |
56. | MligTC455_14458 | 16 | 0.34 | Mlig455_049424 | Neo: - Age: - |
0.968 | - | - | - | - | 0.968 | - | Mlig455_049424 {REF} {Length: 829} {NoTransDecoderORF} {RNA1310_44679} | |
57. | MligTC455_32359 | 194 | 4.04 | Mlig455_054395, Mlig455_054418, Mlig455_070496 | Neo: - Age: - Region-enriched R2: 3.120/0.02401 |
STON2 | 0.967 | 0.967 | - | - | - | - | - | Mlig455_054395 {REF} {Length: 3807} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=152.1]} {Human: ENSG00000140022, STON2, stonin 2, [RH, Score=281, Expect=5e-80]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [RH, Score=285, Expect=3e-82]} {Dmel: FBgn0016975, stnB, stoned B, [RH, Score=374, Expect=3e-112]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [RH, Score=356, Expect=3e-104]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [RH, Score=684, Expect=0.0]} {RNA1509_39423} {RNA1310_6760} {RNA815_11749} Mlig455_054418 {REF} {Length: 3915} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=153.1]} {Human: ENSG00000140022, STON2, stonin 2, [RH, Score=281, Expect=3e-80]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [RH, Score=284, Expect=5e-82]} {Dmel: FBgn0016975, stnB, stoned B, [RH, Score=374, Expect=4e-112]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [RH, Score=355, Expect=4e-104]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [RH, Score=686, Expect=0.0]} {RNA1509_39423} {RNA1310_6760, RNA1509_39423} {RNA1509_39423, RNA815_11749} Mlig455_070496 {REF} {Length: 3566} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=76.5]} {Human: ENSG00000140022, STON2, stonin 2, [Score=178, Expect=9e-46]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [Score=182, Expect=2e-47]} {Dmel: FBgn0016975, stnB, stoned B, [Score=250, Expect=7e-70]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [Score=235, Expect=1e-64]} {Smed: dd_Smed_v6_6859_0_2, dd_Smed_v6_6859_0_2, [Score=467, Expect=5e-152]} {RNA1509_39423} {RNA1310_6760} {RNA815_11749} |
58. | MligTC455_33637 | 187 | 3.9 | Mlig455_027211, Mlig455_027458 | Neo: - Age: - Region-enriched R2: 3.458/0.04514 |
CHRNA10, CHRNA7 | 0.967 | 0.967 | - | - | - | - | - | Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2} Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2} |
59. | MligTC455_52814 | 47 | 0.97 | Mlig455_047356, Mlig455_047365 | Neo: - Age: - |
CNTN2 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_047356 {REF} {Length: 2537} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=57.8]; Immunoglobulin domain [PF13927.8, score=52.6]; Immunoglobulin domain [PF13895.8, score=40.4]; Immunoglobulin domain [PF00047.27, score=40.3]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=25.9]} {Human: ENSG00000184144, CNTN2, contactin 2, [Score=58.5, Expect=3e-08]} {Mouse: ENSMUSG00000053024, Cntn2, contactin 2, [Score=56.6, Expect=8e-08]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=55.1, Expect=2e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=54.7, Expect=3e-07]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=58.2, Expect=2e-08]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [RH, Score=99.8, Expect=2e-22]} {RNA1509_60115} {RNA1310_31768} {RNA815_18728} Mlig455_047365 {REF} {Length: 3489} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=57.9]; Immunoglobulin domain [PF13927.8, score=52.8]; Immunoglobulin domain [PF13895.8, score=40.5]; Immunoglobulin domain [PF00047.27, score=40.3]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.4]} {Human: ENSG00000184144, CNTN2, contactin 2, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000053024, Cntn2, contactin 2, [Score=55.5, Expect=1e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=53.9, Expect=5e-07]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=53.5, Expect=6e-07]; ENSMUSG00000055022, Cntn1, contactin 1, [Score=52.8, Expect=1e-06]; ENSMUSG00000030075, Cntn3, contactin 3, [Score=52.8, Expect=1e-06]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=55.5, Expect=1e-07]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [RH, Score=99.8, Expect=1e-22]} {RNA1509_60115} {RNA1310_31768} {RNA815_19521} |
60. | MligTC455_11497 | 60 | 1.24 | Mlig455_038567 | Neo: - Age: - |
0.964 | - | - | 0.964 | - | - | - | Mlig455_038567 {REF} {Length: 443} {NoTransDecoderORF} {RNA1509_51837} {RNA1310_23145} {RNA815_41033.2} | |
61. | MligTC455_06578 | 32 | 0.67 | Mlig455_026520, Mlig455_026620 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_026520 {REF} {Length: 631} {NoTransDecoderORF} Mlig455_026620 {REF} {Length: 2186} {RNA1509_4420} {RNA1310_2560} {RNA815_2113.1} |
|
62. | MligTC455_28143 | 18 | 0.37 | Mlig455_051026 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_051026 {REF} {Length: 2933} {TRANSSPLICED} {Smed: dd_Smed_v6_17025_0_1, dd_Smed_v6_17025_0_1, [Score=43.9, Expect=6e-06]} {RNA1509_59938} {RNA1310_850} {RNA815_1208.1} | |
63. | MligTC455_07885 | 11 | 0.23 | Mlig455_019901 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_019901 {REF} {Length: 265} {TRANSSPLICED} {NoTransDecoderORF} | |
64. | MligTC455_34573 | 22 | 0.46 | Mlig455_013492 | Neo: - Age: - Region-enriched R5: 3.121/0.03610 |
0.958 | - | - | - | - | 0.958 | - | Mlig455_013492 {REF} {Length: 1142} {NoTransDecoderORF} {RNA1509_9817} {RNA1310_64841} {RNA815_42585} | |
65. | MligTC455_12841 | 12 | 0.25 | Mlig455_068006 | Neo: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_068006 {REF} {Length: 1150} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=55.2]; Immunoglobulin domain [PF13927.8, score=36.7]; Immunoglobulin V-set domain [PF07686.19, score=28.0]; Immunoglobulin domain [PF13895.8, score=23.4]; Immunoglobulin domain [PF00047.27, score=20.3]} {Mouse: ENSMUSG00000061462, Obscn, obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF, [Score=48.1, Expect=1e-05]} {Dmel: FBgn0086906, sls, sallimus, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00006759, unc-22, Twitchin, [Score=48.5, Expect=7e-06]} {Smed: dd_Smed_v6_2544_0_1, dd_Smed_v6_2544_0_1, [Score=82.8, Expect=6e-17]} {RNA1509_30594} {RNA1310_45, RNA1509_30594} {RNA1509_30594, RNA815_17} | |
66. | MligTC455_29058 | 508 | 10.59 | Mlig455_061705 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=2.220 Region-enriched R2: 1.827/0.04316 |
0.956 | - | - | 0.956 | - | - | - | Mlig455_061705 {REF} {Length: 4490} {RNA1509_26411, RNA1509_47712, RNA1509_51111, RNA1509_57920} {RNA1310_63.1, RNA1509_47712, RNA1509_51111, RNA1509_57920} {RNA1509_47712, RNA1509_51111, RNA1509_57920, RNA815_23.1} | |
67. | MligTC455_12997 | 42 | 0.88 | Mlig455_064114 | Neo: - Age: - |
0.955 | 0.955 | - | - | - | - | - | Mlig455_064114 {REF} {Length: 2287} {RNA1509_38652} {RNA1310_6256} {RNA815_46748.1} | |
68. | MligTC455_14372 | 41 | 0.84 | Mlig455_048281 | Neo: - Age: - |
0.955 | - | 0.955 | - | - | - | - | Mlig455_048281 {REF} {Length: 1396} {Pfam: Sulfotransferase domain [PF19798.1, score=52.4]} {RNA1310_42847} {RNA815_35707} | |
69. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
0.954 | - | 0.954 | - | - | - | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
70. | MligTC455_10810 | 6 | 0.12 | Mlig455_069505 | Neo: - Age: - |
0.954 | - | 0.954 | - | - | - | - | Mlig455_069505 {REF} {Length: 376} {NoTransDecoderORF} {RNA1310_40761} | |
71. | MligTC455_11661 | 4 | 0.08 | Mlig455_019371, Mlig455_059103 | Neo: - Age: - |
0.954 | - | 0.954 | - | - | - | - | Mlig455_019371 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} Mlig455_059103 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} |
|
72. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 0.954 | - | 0.954 | - | - | - | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
73. | MligTC455_21684 | 5 | 0.11 | Mlig455_014284, Mlig455_014320, Mlig455_014336 | Neo: - Age: logFC(26M/2M)=-0.541 |
HECA | 0.954 | - | 0.954 | - | - | - | - | Mlig455_014284 {REF} {Length: 1986} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} Mlig455_014320 {REF} {Length: 2086} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685, RNA1509_12340} {RNA1509_12340, RNA815_9766} Mlig455_014336 {REF} {Length: 2009} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=7e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=166, Expect=6e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} |
74. | MligTC455_26801 | 7 | 0.14 | Mlig455_024981 | Neo: - Age: - |
0.954 | - | 0.954 | - | - | - | - | Mlig455_024981 {REF} {Length: 847} {RNA1310_42506} {RNA815_41145} | |
75. | MligTC455_32740 | 3 | 0.06 | Mlig455_055569 | Neo: - Age: - |
NYNRIN | 0.954 | - | - | - | - | - | 0.954 | Mlig455_055569 {REF} {Length: 5134} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=119.3]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=106.5]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=62.2]; Integrase zinc binding domain [PF17921.3, score=57.3]; Integrase core domain [PF00665.28, score=48.5]; Integrase core domain [PF13683.8, score=21.1]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=74.3, Expect=1e-12]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=71.6, Expect=7e-12]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=279, Expect=4e-78]} {RNA1509_23236} {RNA1310_35877} {RNA815_23350} |
76. | MligTC455_12467 | 76 | 1.57 | Mlig455_069096 | Neo: - Age: - |
0.953 | - | - | 0.953 | - | - | - | Mlig455_069096 {REF} {Length: 1425} {Pfam: Integrase core domain [PF00665.28, score=32.9]} {Smed: dd_Smed_v6_11155_0_2, dd_Smed_v6_11155_0_2, [Score=56.6, Expect=4e-10]} {RNA1509_21400} {RNA1310_576.1} {RNA815_2733.1} | |
77. | MligTC455_47482 | 13 | 0.27 | Mlig455_003581, Mlig455_015414 | Neo: - Age: - |
0.952 | - | 0.952 | - | - | - | - | Mlig455_003581 {REF} {Length: 2173} {Pfam: Wnt and FGF inhibitory regulator [PF13908.8, score=32.6]} {RNA1509_33693} {RNA1310_49791.1} {RNA815_19959} Mlig455_015414 {REF} {Length: 2223} {Pfam: Wnt and FGF inhibitory regulator [PF13908.8, score=32.3]} {RNA1509_33693} {RNA1310_49791.1} {RNA815_19959} |
|
78. | MligTC455_49361 | 59 | 1.23 | Mlig455_052806 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_052806 {REF} {Length: 2973} {Pfam: F5/8 type C domain [PF00754.27, score=25.2]} {Smed: dd_Smed_v6_36585_0_1, dd_Smed_v6_36585_0_1, [Score=46.2, Expect=5e-06]} {RNA1310_23370} {RNA815_18000} | |
79. | MligTC455_16528 | 213 | 4.44 | Mlig455_065279 | Neo: - Age: Up-Down-Down |
MADD | 0.951 | - | - | 0.951 | - | - | - | Mlig455_065279 {REF} {Length: 2038} {Human: ENSG00000110514, MADD, MAP kinase activating death domain, [Score=69.7, Expect=2e-13]} {Mouse: ENSMUSG00000040687, Madd, MAP-kinase activating death domain, [Score=71.6, Expect=4e-14]} {Dmel: FBgn0030613, Rab3-GEF, Rab3 GDP-GTP exchange factor, [Score=60.1, Expect=3e-10]} {Celegans: WBGene00000086, aex-3, MAP kinase-activating death domain protein, [Score=63.9, Expect=9e-12]} {Smed: dd_Smed_v6_8355_0_12, dd_Smed_v6_8355_0_12, [Score=66.6, Expect=9e-13]} {RNA1509_32884} {RNA1310_25902} {RNA815_13149} |
80. | MligTC455_19784 | 19 | 0.39 | Mlig455_053657 | Neo: - Age: - |
ACE | 0.951 | - | - | - | - | 0.951 | - | Mlig455_053657 {REF} {Length: 2540} {Pfam: Angiotensin-converting enzyme [PF01401.20, score=635.5]} {Human: ENSG00000159640, ACE, angiotensin I converting enzyme, [Score=436, Expect=3e-143]; ENSG00000264813, AC113554.1, novel transcript, [Score=433, Expect=2e-142]} {Mouse: ENSMUSG00000020681, Ace, angiotensin I converting enzyme (peptidyl-dipeptidase A) 1, [Score=439, Expect=5e-145]} {Dmel: FBgn0012037, Ance, Angiotensin converting enzyme, [RH, Score=441, Expect=5e-147]} {Celegans: WBGene00000039, acn-1, Inactive angiotensin-converting enzyme-related protein, [Score=184, Expect=6e-49]} {Smed: dd_Smed_v6_6160_0_1, dd_Smed_v6_6160_0_1, [Score=356, Expect=3e-114]} {RNA1509_11014} {RNA1310_39654} {RNA815_34873} |
81. | MligTC455_41390 | 13 | 0.27 | Mlig455_001970 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_001970 {REF} {Length: 361} {NoTransDecoderORF} {RNA1310_88179} | |
82. | MligTC455_12116 | 106 | 2.2 | Mlig455_004661, Mlig455_004728 | Neo: - Age: Up-Up-Down |
0.95 | - | 0.950 | - | - | - | - | Mlig455_004661 {REF} {Length: 3441} {RNA1509_48407} {RNA1310_2938.1} {RNA815_14343.2} Mlig455_004728 {REF} {Length: 2670} {RNA1509_48407} {RNA1310_45267.1, RNA1509_48407} {RNA1509_48407, RNA815_58661} |
|
83. | MligTC455_28324 | 96 | 1.99 | Mlig455_008984 | Neo: - Age: - |
0.95 | - | - | 0.950 | - | - | - | Mlig455_008984 {REF} {Length: 330} {Pfam: Integrase core domain [PF00665.28, score=34.8]} {Smed: dd_Smed_v6_11155_0_1, dd_Smed_v6_11155_0_1, [Score=57.4, Expect=4e-10]} {RNA1509_21400} {RNA1310_576.1} {RNA815_2733.1} | |
84. | MligTC455_37135 | 7 | 0.15 | Mlig455_066842 | Neo: - Age: - |
P2RX4 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_066842 {REF} {Length: 2017} {Pfam: ATP P2X receptor [PF00864.21, score=462.0]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=362, Expect=2e-122]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=343, Expect=2e-115]} {Smed: dd_Smed_v6_9166_0_1, dd_Smed_v6_9166_0_1, [RH, Score=404, Expect=2e-139]} {RNA1509_24762} {RNA1310_16818.1, RNA1509_24762} {RNA1509_24762, RNA815_22360} |